Show simple item record

How are we addressing axial psoriatic arthritis in clinical practice?

dc.contributor.authorMichelena, Xabier
dc.contributor.authorLópez Medina, Clementina
dc.contributor.authorDe Miguel, Eugenio
dc.contributor.authorMoreno Ramos, Manuel José
dc.contributor.authorQueiro Silva, Rubén 
dc.contributor.authorMarzo Ortega, Helena
dc.contributor.authorJuanola, Xavier
dc.date.accessioned2025-03-14T08:51:14Z
dc.date.available2025-03-14T08:51:14Z
dc.date.issued2024
dc.identifier.citationRheumatology and Therapy (2024); doi:10.1007/s40744-024-00722-w
dc.identifier.issn2198-6576
dc.identifier.issn2198-6584
dc.identifier.urihttps://hdl.handle.net/10651/77638
dc.description.sponsorshipNovartis Farmaceutica S.A., Spain; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (LBRC)
dc.language.isoeng
dc.relation.ispartofRheumatology and Therapy
dc.rights©,
dc.sourceWOS:001335349000001
dc.titleHow are we addressing axial psoriatic arthritis in clinical practice?
dc.typejournal article
dc.identifier.doi10.1007/s40744-024-00722-w
dc.relation.publisherversionhttp://dx.doi.org/10.1007/s40744-024-00722-w


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record